Stellantis to Bring Human-Centered Mobility Vision to CES 2027 Keynote
Press Release

Stellantis to Bring Human-Centered Mobility Vision to CES 2027 Keynote

CEO Antonio Filosa to showcase how Stellantis is leveraging technology to make mobility smarter and more personal ARLINGTON, Va., Sept. 8, 2026 /PRNewswire/ — The Consumer Technology Association (CTA)®, owner and producer of CES®, announces Stellantis CEO, Antonio Filosa, will deliver a keynote on the opening day of CES 2027 on January 6. Filosa will highlight […]

Read More
Stoke Space Technologies Raises $1 Billion Series E: NYSE Content Update
Press Release

Stoke Space Technologies Raises $1 Billion Series E: NYSE Content Update

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Sept. 8, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins.  Kristen Scholer delivers the pre-market update on September 8th Stoke […]

Read More
Aurzen Shines at IFA 2026, Garnering 11 Honors Across Its Projector Lineup
Press Release

Aurzen Shines at IFA 2026, Garnering 11 Honors Across Its Projector Lineup

IRVINE, Calif., Sept. 8, 2026 /PRNewswire/ — Aurzen made a strong impression at IFA 2026, with its latest projectors earning recognition from media and the show’s own innovation award. Aurzen Shines at IFA 2026, Garnering 11 Honors Across Its Projector Lineup The Aurzen ZIP Pro appeared in best-of-IFA coverage from The Verge, Pocket-lint, Android Central, CGMagazine, […]

Read More
Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.93 Million Tokens, and Total Crypto and Total Cash Holdings of $15.7 Billion
Press Release

Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.93 Million Tokens, and Total Crypto and Total Cash Holdings of $15.7 Billion

Bitmine owns 4.9% of the total ETH coin supply of 122.0 million Bitmine is 97% of the way to the ‘Alchemy of 5%’ in just 15 months Crypto equities are largest contributor to Russell 1000 quarter to date, representing 4 of the top 21 stocks Bitmine common stock gain of 99% quarter to date is […]

Read More
ClubMed Lifestyle Group Advances Global Expansion Through Industry Collaboration and AI Application
Press Release

ClubMed Lifestyle Group Advances Global Expansion Through Industry Collaboration and AI Application

HONG KONG, Sept. 8, 2026 /PRNewswire/ — ClubMed Lifestyle Group, a subsidiary of Fosun International Limited (656), has joined the World Travel & Tourism Council (WTTC) as a Global Member. The membership was announced by WTTC on August 28. ClubMed Lifestyle Group operates premium all-inclusive resorts with Club Med as its core brand. It also […]

Read More
As Global Heatwaves Intensify, Kolmar Korea Brings Cooling Innovation to Sunscreen
Press Release

As Global Heatwaves Intensify, Kolmar Korea Brings Cooling Innovation to Sunscreen

Kolmar Korea advances K-sun care with non-menthol cooling ingredients, water-drop technology, and a high-moisture Jelly Sun Stick New cooling formulations lower skin temperature by approximately 4–6°C while delivering robust UV protection SEOUL, South Korea, Sept. 8, 2026 /PRNewswire/ — Kolmar Korea, a driving force behind the global rise of K-beauty sunscreens, is capturing industry attention for […]

Read More
Alebund Pharmaceuticals Announces FDA Clearance of IND Application for AP308 for the Treatment of IgA Nephropathy
Press Release

Alebund Pharmaceuticals Announces FDA Clearance of IND Application for AP308 for the Treatment of IgA Nephropathy

SHANGHAI, Sept. 8, 2026 /PRNewswire/ — Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; HKEX: 09637), a renal-focused biopharmaceutical company, today announced that it has recently received clearance from the U.S. Food and Drug Administration (FDA) of its Investigational New Drug (IND) application for AP308, a first-in-class engineered recombinant IgA protease. The Company plans to initiate […]

Read More
Accro Bioscience Announces IND Clearance from NMPA for Phase II/III Clinical Trial of AC-201, a Highly Selective TYK2/JAK1 Inhibitor for the Treatment of Non-Segmental Vitiligo
Press Release

Accro Bioscience Announces IND Clearance from NMPA for Phase II/III Clinical Trial of AC-201, a Highly Selective TYK2/JAK1 Inhibitor for the Treatment of Non-Segmental Vitiligo

NEW YORK and SUZHOU, China, Sept. 8, 2026 /PRNewswire/ — Accro Bioscience (Suzhou) Limited ("Accro") today announced that Shanghai Fosun Pharmaceutical Industrial Development Company Limited ("Fosun Pharma Industrial"), a subsidiary of its partner Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"), has received approval from China’s National Medical Products Administration (NMPA) to conduct a Phase […]

Read More

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.